NEW YORK -Friday 29 October 2021 [ AETOS Wire ]

Cirium’s new tool, DiioTM Schedule Snapshot, reveals how the top four US airlines removed 20% of the flights from the schedule originally published only four months earlier.
By comparison, only 3% of flights were removed from the schedule in summer 2019.
Insights from Diio Schedule Snapshot highlight the significant change to the planning window, which is more dynamic because of the pandemic.
The new offering enables airlines and airports to analyze airline schedule changes with much more detail than in the past, tracking trends over time.
(BUSINESS WIRE)-- The new DiioTM Schedule Snapshot offering released by Cirium, the aviation analytics firm, reveals how planning by the major US airlines changed over the summer, with 20% of flights being removed from their schedule for September.

At the start of May 2021, the plan for what carriers would fly in September was more or less in line with pr ... Read more »

 ARLINGTON, Va.--Friday 29 October 2021 [ AETOS Wire ]

(BUSINESS WIRE)-- Fluence, a leading global provider of energy storage products and services and digital applications for renewables and storage, today announced the pricing of its initial public offering of 31,000,000 shares of its Class A common stock at a price to the public of $28.00 per share. The shares of Class A common stock are expected to begin trading on the Nasdaq Global Select Market on October 28, 2021, under the ticker symbol “FLNC.” The initial public offering is expected to close on November 1, 2021, subject to customary closing conditions.

In addition, Fluence has granted the underwriters a 30-day option to purchase up to an additional 4,650,000 shares of its Class A common stock at the initial public offering price, less underwriting discounts and commissions.

J.P. Morgan Securities LLC, Morgan Stanley, Barclays Capital Inc., and BofA Securities are acting as joint lead ... Read more »

• BioNTech signs Memorandum of Understanding with Rwandan Government and the Institut Pasteur de Dakar. Construction is planned to be initiated of the first mRNA manufacturing facility in Africa in mid-2022

• First manufacturing facility will become a node in a decentralized and robust African end-to-end manufacturing network

• Development and implementation of a scalable regional manufacturing network to enable an annual manufacturing capacity of several hundreds of million mRNA vaccine doses

KIGALI, Rwanda-Thursday 28 October 2021 [ AETOS Wire ]

(BUSINESS WIRE) -- BioNTech SE today announced that the Company plans to initiate the construction of the first state-of-the-art manufacturing site for mRNA-based vaccines in the African Union in mid-2022. This is the next step in BioNTech’s efforts to implement sustainable end-to-end vaccine supply solutions on the African continent. The decision is the result of a meeting between Rwand ... Read more »

 Underscores MSCI’s commitment to increase ESG transparency and data for investors globally

NEW YORK -Friday 29 October 2021 [ AETOS Wire ]

(BUSINESS WIRE)-- With the critical COP26 conference just around the corner, investors are seeking new levels of transparency into the alignment of listed companies with global climate goals. MSCI (NYSE: MSCI), a leading provider of critical decision support tools and services for the global investment community, announced today it has made the Implied Temperature Rise of over 2,900 companies (constituents of MSCI ACWI Index) publicly available on its website, to allow investors access to the data and transparency required to navigate their transition to net-zero.

Implied Temperature Rise provides clarity and transparency on the climate commitments of listed companies by assessing their commitments to net-zero emissions using a simplified and powerful forward-looking metric: companies’ alig ... Read more »

OSAKA, Japan, & LONDON -Friday 29 October 2021 [ AETOS Wire ]

− Acquisition expands Takeda’s immuno-oncology and innate immune cell therapy portfolio with novel platforms leveraging γδT cells for the potential treatment of solid tumors and hematological malignancies

− As result of successful “build-to-buy” collaboration, Takeda to exercise its right to acquire GammaDelta Therapeutics for a pre-negotiated upfront and future potential milestone payments, subject to certain adjustments

(BUSINESS WIRE)-- Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced the exercise of its option to acquire GammaDelta Therapeutics Limited (“GammaDelta”), a company focused on exploiting the unique properties of gamma delta (γδ) T cells for immunotherapy. Through the acquisition, Takeda will obtain GammaDelta’s allogeneic variable delta 1 (Vδ1) gamma-delt ... Read more »

Kymeta tests future connectivity capabilities using private LTE on the CBRS spectrum band using its state-of-the-art u8 terminal with integration to off-the-shelf products including Accelleran to successfully demonstrate range, performance, and resilience from the cloud via their satellite user terminal to a smartphone

REDMOND, Wash.-Friday 29 October 2021 [ AETOS Wire ]

(BUSINESS WIRE)-- Kymeta (www.kymetacorp.com), the communications company making mobile global, announced today the successful testing of private Long Term Evolution (LTE) small cell on Citizens Broadband Radio Service (CBRS), demonstrating a complete connectivity solution that provides users with more reliable and robust connectivity directly to their smartphone and CBRS capable devices.

The trial was performed at Kymeta headquarters with a Kymeta™ u8 terminal, an off-the-shelf core running on an ARM single board compute (SBC), and an Accelleran small cell. The system delivers a ... Read more »

INGELHEIM, Germany -Friday 29 October 2021 [ AETOS Wire ]

The marketing authorization application (MAA) package includes results from the pivotal Effisayil-1 global trial
(BUSINESS WIRE)-- Boehringer Ingelheim announced today that the company’s marketing authorization application (MAA) for the treatment of flares in generalized pustular psoriasis (GPP), has been validated and is now under evaluation with the European Medicines Agency (EMA).

“GPP is a rare, life-threatening neutrophilic skin disease characterized by painful, sterile pus-filled blisters, that can suddenly appear over the body,” said Dr. Janine Lamar, Global Spesolimab Lead at Boehringer Ingelheim. “Despite its name, GPP is very different to the more common plaque psoriasis. With no approved treatments in the EU for GPP flares, acceptance of the application for review of spesolimab brings us one step closer to providing a targeted treatment for people with this distressing, ... Read more »

NEW YORK-Friday 29 October 2021 [ AETOS Wire ]

(BUSINESS WIRE)-- SDCL EDGE Acquisition Corporation (the “Company”) announced today that it priced its initial public offering of 17,500,000 units at $10.00 per unit. The units will be listed on The New York Stock Exchange (“NYSE”) and trade under the ticker symbol “SEDA.U” beginning October 29, 2021. Each unit consists of one Class A ordinary share and one-half of one redeemable warrant. Each whole warrant entitles the holder thereof to purchase one Class A ordinary share at a price of $11.50 per share. Once the securities comprising the units begin separate trading, the Class A ordinary shares and redeemable warrants are expected to be listed on the NYSE under the symbols “SEDA” and “SEDA WS”, respectively. The offering is expected to close on November 2, 2021, subject to customary closing conditions.

Goldman Sachs & Co. LLC and BofA Securities, Inc. are a ... Read more »

Team of top global gaming streamers unite to represent the brand and engage with fans worldwide

BOSTON -Friday 29 October 2021 [ AETOS Wire ]

(BUSINESS WIRE)-- Gillette (NYSE: PG), the world’s leading expert in men’s grooming, announced today the return of the Gillette Gaming Alliance -- a team of global streamers selected to represent the brand and create content for audiences worldwide. The Gillette Gaming Alliance, which is back for its fourth consecutive year, features the largest roster to date – with streamers representing a total of 11 countries – making it a truly worldwide edition.

Each member of the Alliance will create custom content streams as well as highlight their shaving routines, personal style and Gillette’s newest innovation, core products including ProGlide and SkinGuard, initiatives such as Movember, and promotions when applicable. Members will come together for co-stream opportunities, also known as squad st ... Read more »

The initiative features world-renowned thought leaders, including British-American fashion designer and philanthropist Tan France, 2020 TIME Kid of the Year Gitanjali Rao, and UK robotics scientist Dr. Peter Scott-Morgan

RESEARCH PARK TRIANGLE, N.C.-Friday 29 October 2021 [ AETOS Wire ]

(BUSINESS WIRE)-- Today, Lenovo™ (HKSE: 992) (ADR: LNVGY) launches the Kind City project—a vision to change urban environments forever and create future cities built on kindness.

By championing empathy in society, the project strives to encourage stronger, more inclusive communities made possible through smarter technology, and restore kindness in places where citizens feel increasingly disconnected.

Lenovo’s Kind City is the biggest crowdsourced public ‘census’ to imagine and co-author a blueprint for a city of the future built on kindness. It’s mission? To bring a more empathetic future to life through insight from global research, ... Read more »

 Leading food ingredients manufacturer advances strategic business initiatives and overseas expansion by optimizing support for its JD Edwards Software

LAS VEGAS-Friday 29 October 2021 [ AETOS Wire ]

(BUSINESS WIRE)-- Rimini Street, Inc. (Nasdaq: RMNI), a global provider of enterprise software products and services, the leading third-party support provider for Oracle and SAP software products and a Salesforce partner, today announced that Mitsubishi Corporation Life Sciences, a food ingredients manufacturer within Mitsubishi Corporation’s Food Industry Group, has switched to Rimini Street Support for its JD Edwards applications. Switching from the vendor’s support to Rimini Street has enabled the company to dramatically reduce its maintenance costs and free up internal resources for strategic initiatives. By freeing up critical resources – time, money and personnel – Mitsubishi Corporation Life Sciences is able to begin inv ... Read more »

NEW YORK -Friday 29 October 2021 [ AETOS Wire ]

(BUSINESS WIRE)-- The Women’s Entrepreneurship Accelerator (WEA), a strategic multi-partnership convening five UN agencies and Mary Kay Inc., is today joining forces with the Commonwealth Businesswomen’s Network (CBWN) to empower and support underserved women entrepreneurs across the 54 countries of the Commonwealth.

WEA is designed to maximize the development impact of women entrepreneurship in achieving the Sustainable Development Goals (SDGs) by creating an enabling ecosystem for women entrepreneurs that fosters growth, sustainability, and resilience. In June 2021, WEA joined the Generation Equality Forum in Paris and committed to empower five million women around the world by 2030 to accelerate progress for gender equality.

WEA recently announced the launch of a series of impactful initiatives and knowledge products, all shaped through a gender lens, as the joint outcome of the collaboration betw ... Read more »

CAMBRIDGE, England -Friday 29 October 2021 [ AETOS Wire ]

Dr Hermann Hauser, serial entrepreneur, co-founder of Amadeus Capital Partners and founder of semiconductor company, Arm Ltd, and gene-sequencing company, Solexa / Illumina, joins as chair of the board.
Sir Greg Winter, Nobel-winning scientist, and known for his work on monoclonal antibodies, is the founder of multiple successful biotech companies.
Alan S. Roemer, biotechnology entrepreneur who launched Pharmasset and Roivant Sciences, has raised over $1.75 billion in private and public capital and consummated five IPOs.
(BUSINESS WIRE)-- Today bit.bio welcomes three new members to its board of directors, who bring their respective experience of turning world class science into new industries and company growth. The new directors will provide important guidance as bit.bio scales their proprietary synthetic biology cell programming technology platform, creating products and solutions based on human ce ... Read more »